Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

BACKGROUND: Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor c...

Descripción completa

Detalles Bibliográficos
Autores principales: Grima, Daniel T, Brown, Stephen T, Kamboj, Laveena, Bainey, Kevin R, Goeree, Ron, Oh, Paul, Ramanathan, Krishnan, Goodman, Shaun G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908913/
https://www.ncbi.nlm.nih.gov/pubmed/24493930
http://dx.doi.org/10.2147/CEOR.S51052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908913/
https://www.ncbi.nlm.nih.gov/pubmed/24493930
http://dx.doi.org/10.2147/CEOR.S51052

Ejemplares similares